Evaluation of the Antidepressant Like Activity of Ethanolic Extract of Calendula officinalis using Rodent Models (Wistar Rat) of Depression

Author(s): Kaur Rajwinder, Rajmeet Singh*, Lalit, Kaur Jaswinder, Rajat

Journal Name: Current Psychopharmacology

Volume 9 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Depression disorder has been considered to be the global common psychological CNS disorder affecting about 121 million people worldwide and is among the leading causes of disability that not only inflicts suffering but also carries a high economic burden. Calendula officinalis L. (Marigold) is globally known for its medicinal importance containing various phytochemicals including terpenoids, quinones, coumarins and other constituents, showing some important biological activities like immuno-stimulant, hepatoprotective, antioxidant, etc. activities with no toxic effect.

Objective: This study aims to evaluate the antidepressant effect of ethanolic extract of Calendula officinalis using rodent models (Wistar rat) of depression.

Methods: The present study was carried out to evaluate the antidepressant effect of ethanolic extract of Calendula officinalis in Wistar rat. This effect was determined by recording the immobility time in Forced Swim Test (FST) and a number of squares crossing and rearing in Open Field Test (OFT). The rats were randomly divided into 5 groups. Rats belonged to group 1 act as control group and group 2 were given Imipramine (10 mg/kg, i.p.) which act as standard group.Wistar rats were treated i.p. with Ethanolic extract of Calendula officinalis group 3, 4 and 5 were given 100mg/kg, 200mg/kg and 400mg/kg respectively.

Results: The effect of rat model of depression i.e. Forced Swim Test (FST) and Open Field Test (OFT) model indicated that Ethanolic extract of Calendula officinalis showed potent to moderate antidepressant effect (decrease in immobility time and increase in number of square crossing and rearing) as compared to normal group. The drug might act as monoamine oxidase inhibitors.

Conclusion: Taken all together, the present study concluded that the drug EECO was to exert antidepressant effects by inhibiting the monoamine oxidase-A (MAO-A) reaction, which is responsible for the regulation of the metabolism of the neurotransmitter 5-hydroxytryptamine (5-HT) in the brain. This drug might act as monoamine oxidase inhibitors (MAO-inhibitors) hence may increase the levels of norepinephrine, dopamine and serotonin; and decrease the levels of GABA in the brain.

Keywords: Antidepressant, Calendula officinalis, dopamine, imipramine, MAO-inhibitors, norepinephrine, rearings, serotonin.

[1]
Singer A, Schmidt M, Hauke W, Stade K. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial. Phytomedicine 2011; 18(8-9): 739-42.
[http://dx.doi.org/10.1016/j.phymed.2011.02.016] [PMID: 21514125]
[2]
Cassani J, Ferreyra-Cruz OA, Dorantes-Barrón AM, Villaseñor RM, Arrieta-Baez D, Estrada-Reyes R. Antidepressant-like and toxicological effects of a standardized aqueous extract of Chrysactinia mexicana A. Gray (Asteraceae) in mice. J Ethnopharmacol 2015; 171: 295-306.
[http://dx.doi.org/10.1016/j.jep.2015.05.055] [PMID: 26070520]
[3]
de Sousa DP, Schefer RR, Brocksom U, Brocksom TJ. Synthesis and antidepressant evaluation of three para-benzoquinone mono-oximes and their oxy derivatives. Molecules 2006; 11(2): 148-55.
[http://dx.doi.org/10.3390/11020148] [PMID: 17962785]
[4]
Oestergaard S, Moldrup C. Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological intervention. Public Health 2011; 125: 358-67.
[http://dx.doi.org/10.1016/j.puhe.2011.02.001]
[5]
Briley M, Chopin P, Marien M, Moret C. Functional neuropharmacology of compounds acting at 5-HT 1B/D receptors. Serotoninergic neurons and 5-HT Receptors in the CNS. Springer: Berlin Heidelberg 2000; pp. 269-91.
[http://dx.doi.org/10.1007/978-3-642-60921-3_10]
[6]
Reynolds EH. Brain and mind: a challenge for WHO. Lancet 2003; 361(9373): 1924-5.
[http://dx.doi.org/10.1016/S0140-6736(03)13600-8] [PMID: 12801732]
[7]
Bandaruk Y, Mukai R, Terao J. Cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells. Toxicol Rep 2014; 1: 639-49.
[http://dx.doi.org/10.1016/j.toxrep.2014.08.016] [PMID: 28962277]
[8]
Yan SX, Lang JL, Song YY, et al. Studies on anti-depressant activity of four flavonoids isolated from Apocynum venetum Linn (Apocynaceae) leaf in mice. Trop J Pharm Res 2015; 14(12): 2269-77.
[http://dx.doi.org/10.4314/tjpr.v14i12.17]
[9]
Machado DG, Bettio LE, Cunha MP, et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 2008; 587(1-3): 163-8.
[http://dx.doi.org/10.1016/j.ejphar.2008.03.021] [PMID: 18457827]
[10]
Kuri S, Billah MM, Rana SM, et al. Phytochemical and in vitro biological investigations of methanolic extracts of Enhydra fluctuans Lour. Asian Pac J Trop Biomed 2014; 4(4): 299-305.
[http://dx.doi.org/10.12980/APJTB.4.2014C677] [PMID: 25182555]
[11]
Hamad MN, Mohammed HJ, Merdaw MA. Antibacterial activity of Calendula officinalis flowers in vitro. Ibn Al-Haitham J Pure App Sci 2011; 24(3): 143-9.
[12]
Preethi KC, Kuttan G, Kuttan R. Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian J Exp Biol 2009; 47(2): 113-20.
[PMID: 19374166]
[13]
Kumar A, Singh P, Dora J. Phytochemistry and Pharmacological activities of Calendula officinalis. Internat J Invent Pharm Sci 2013; 1(1): 59-63.
[14]
Mullaicharam AR, Amaresh NB, Balasubramanian H. phytochemistry and pleiotropic pharmacological properties of Calendula officinalis Linn. -A Review. J Pharmacognosy Phytochem 2014; 2(4): 1-10.
[15]
Castagné V, Moser P, Roux S, Porsolt RD. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protocols Pharmacol 2010; Chapter 5(1): 8.
[http://dx.doi.org/10.1002/0471141755.ph0508s49] [PMID: 22294373]
[16]
Overstreet DH. Modeling depression in animal models. Methods Mol Biol 2012; 829: 125-44.
[http://dx.doi.org/10.1007/978-1-61779-458-2_7]
[17]
Dantzer R, Walker AK. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) 2014; 121(8): 925-32.
[http://dx.doi.org/10.1007/s00702-014-1187-1] [PMID: 24633997]
[18]
Marchand WR, Dilda V, Jensen CR, Wahlen GE. Neurobiology of mood disorders. Hosp Physician 2005; 41(9): 17.
[19]
Elzorba H, El Bann H, Derbala D. Some pharmacological & toxicological activities of Calendula officinalis Linn. Flower 70% ethanolic extract. Am J Anim Vet Sci 2016; 4(2): 26-31.
[http://dx.doi.org/10.11648/j.avs.20160402.13]
[20]
Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001; 7(5): 541-7.
[http://dx.doi.org/10.1038/87865] [PMID: 11329053]
[21]
Rang HP, Dale MM, Ritter JM, Moore PKV, Eds. Pharmacology. Philadelphia: Churchill Livingstone 2003; pp. 535-49.
[22]
Knoll J, Yoneda F, Knoll B, Ohde H, Miklya I. (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Br J Pharmacol 1999; 128(8): 1723-32.
[http://dx.doi.org/10.1038/sj.bjp.0702995] [PMID: 10588928]
[23]
Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr Med Chem 1998; 5(2): 137-62.
[PMID: 9481038]
[24]
Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455(7215): 894-902.
[http://dx.doi.org/10.1038/nature07455] [PMID: 18923511]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 1
Year: 2020
Page: [58 - 67]
Pages: 10
DOI: 10.2174/2211556009666200217122202
Price: $65

Article Metrics

PDF: 11
HTML: 2